In patients with inflammatory bowel disease (IBD), Hong et al4 showed that GIP testing was associated with increased detection of microbes and lower rates of IBD therapy escalation and endoscopies with no difference in adverse outcomes. This evidence concerns the gene GIP and inflammatory bowel disease.